Barclays analyst Lauren Lieberman downgraded Oddity (ODD) to Underweight from Equal Weight with a price target of $13, down from $40. The company guided to sales being down 30% in Q1 after consistently growing 20%-plus, the analyst tells investors in a research note. Further, Barclays says Oddity has limited visibility into if and when its sales and profitability will stabilize. The firm is concerned that “deeper challenges may emerge.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ODD:
